MIAN
AERI

Mariner Independent Advisor Network’s Aerie Pharmaceuticals AERI Stock Holding History

Mariner Independent Advisor Network’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,140
Closed -$641K – 359
2017
Q1 		$641K Buy
+14,140
New +$631K 0.08% 134

Other funds holding AERI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Mariner Independent Advisor Network's AERI Position: Q2 2017 in Review

Mariner Independent Advisor Network sold out of Aerie Pharmaceuticals (AERI) in Q2 2017, closing a stake of 14,140 shares — an estimated $641K sold.

Mariner Independent Advisor Network first reported a position in AERI in Q1 2017 and held it in 1 quarter. The position peaked at $641K in Q1 2017. 172 funds tracked by Wall St. Rank hold AERI as of Q2 2017.

  • Mariner Independent Advisor Network reported no remaining Aerie Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Mariner Independent Advisor Network sold 14,140 Aerie Pharmaceuticals shares in Q2 2017, an estimated $641K.
  • Mariner Independent Advisor Network first reported a position in Aerie Pharmaceuticals in Q1 2017 and held it in 1 quarter.
  • Mariner Independent Advisor Network's Aerie Pharmaceuticals position peaked at $641K in Q1 2017.
  • 172 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2017.

Based on Mariner Independent Advisor Network's 13F filing for Q2 2017, filed 16 Aug 2017.